Publication Archives: 2011
-
(2010)
Coffey C, Shaw L, Trojanowski J
PPMI Parkinson’s Progression Monitoring Initiative : CSF α-synuclein interlaboratory study.
Parkinson ‘s Progession Markers Initiative; 2011 July 7 PPMI – SYN – RR-1.
-
(2010)
Jason Jensen, Margherita Farina, Giampaolo Zuccheri, Wilfried Grange, Martin Hegner
Quantitative, Label-Free Detection of the Aggregation of α-Synuclein Using Microcantilever Arrays Operated in a Liquid Environment..
Journal of Sensors; http://dx.doi.org/10.1155/2012/874086.
-
(2010)
Dodel, R., Bacher, M., Besong Agbo, D., Hagemann, S., Balzer-geldsetzer, M.
Naturally occuring autoantibodies against alpha-synuclein that inhibit the aggregation and cytotoxicity of alpha-synuclein.
European Patent Application; European Patent Application EP2366714; 2011 Sept. 21.
-
(2010)
Fantini, J., Carlus, D., Yahi, N.
The fusogenic tilted peptide (67–78) of α-synuclein is a cholesterol binding domain.
Biochimica et Biophysica Acta (BBA) – Biomembranes; Volume 1808, Issue 10, 2011 October, Pages 2343–2351.
-
(2010)
Couch, Y, Alvarez-Erviti, L., Sibson, NR, Wood, M and Anthony, D.
The acute inflammatory response to intranigral a-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation.
Journal of Neuroinflammation; 2011, 8:166.
-
(2010)
Weihofen, A., Grimm, J. , Nitsch, R. , Hock, C.
Human Anti-Alpha-Synuclein Antibodies.
United States Patent Application; United States Patent Application 20110300077; 2011 Dec 8; DOI: y2011/0300077.html..
